Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study
- PMID: 17266031
- DOI: 10.1002/ijc.22556
Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study
Abstract
The physical inactivity and obesity involved in hyperglycemia and hyperinsulinemia is supposed to lead to an increased bioavailability of insulin-like growth factor-I (IGF-I). The carcinogenic effect of IGF-I may be influenced by IGF binding proteins. We investigated the association between plasma levels of C-peptide, a surrogate biomarker of insulin, IGFBP-1, IGF-I or IGFBP-3, and the risk of colorectal cancer in a nested case-control study. During an 11.5-year follow-up, 375 newly diagnosed colorectal cancers were identified in a cohort of 38,373 adults who had returned the baseline questionnaire and provided blood samples. Two matched-controls for each case were selected from the cohort. The odds ratio (OR) of colorectal cancer for plasma levels of each protein was estimated using the conditional logistic regression model adjusted for potential confounding factors. We observed a statistically significant association of plasma C-peptide with colorectal cancer only in men. The ORs were 1.0, 2.3, 2.8 and 3.2 along with quartiles (p trend, 0.0072). The association was stronger in colon cancer (p trend, 0.025) than in rectal cancer (p trend, 0.24). Other peptides were not associated with the risk in either men or women. The results did not change when repeatedly analyzed by tumor invasion levels, tumor sites or follow-up periods. In conclusion, a higher plasma C-peptide may indicate a subsequent risk of colorectal cancer in Japanese men.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600. doi: 10.1093/jnci/92.19.1592. J Natl Cancer Inst. 2000. PMID: 11018095
-
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):850-5. doi: 10.1158/1055-9965.EPI-04-0661. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824155
-
A prospective study of plasma C-peptide and colorectal cancer risk in men.J Natl Cancer Inst. 2004 Apr 7;96(7):546-53. doi: 10.1093/jnci/djh082. J Natl Cancer Inst. 2004. PMID: 15069117
-
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.Lancet. 2004 Apr 24;363(9418):1346-53. doi: 10.1016/S0140-6736(04)16044-3. Lancet. 2004. PMID: 15110491 Review.
-
The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.Int J Colorectal Dis. 2006 Apr;21(3):201-8. doi: 10.1007/s00384-005-0776-8. Epub 2005 Jun 16. Int J Colorectal Dis. 2006. PMID: 15959790 Review.
Cited by
-
Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):810-20. doi: 10.1158/1055-9965.EPI-11-1105. Epub 2012 Feb 21. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22354904 Free PMC article.
-
Ketogenic Effects of Multiple Doses of a Medium Chain Triglycerides Enriched Ketogenic Formula in Healthy Men under the Ketogenic Diet: A Randomized, Double-Blinded, Placebo-Controlled Study.Nutrients. 2022 Mar 12;14(6):1199. doi: 10.3390/nu14061199. Nutrients. 2022. PMID: 35334856 Free PMC article. Clinical Trial.
-
Obesity and colorectal cancer risk: a meta-analysis of cohort studies.World J Gastroenterol. 2007 Aug 21;13(31):4199-206. doi: 10.3748/wjg.v13.i31.4199. World J Gastroenterol. 2007. PMID: 17696248 Free PMC article.
-
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.Cancer Res. 2008 Jan 1;68(1):329-37. doi: 10.1158/0008-5472.CAN-07-2946. Cancer Res. 2008. PMID: 18172327 Free PMC article.
-
Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.World J Gastroenterol. 2014 Jun 28;20(24):7941-9. doi: 10.3748/wjg.v20.i24.7941. World J Gastroenterol. 2014. PMID: 24976730 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous